Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Expands Kansas Facilities

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will complete a 30,000-square-feet expansion of its facilities in Lenexa, Kan., a company spokesperson confirmed today.
 
The Kansas facilities, which include four buildings in Lenexa, manufacture the Remel brand of products sold by Thermo Fisher. Those products include microbiology lab products and diagnostics that are sold into the clinical, industrial, and research markets.
 
The spokesperson could not confirm the total cost of the expansion, which has been reported to be around $4 million.
 
The Kansas Bioscience Authority, a state-run initiative aimed at attracting and retaining bioscience research in Kansas, awarded $1.25 million to Thermo Fisher in September 2007 to help pay for the facility expansion. According to the KBA, the Remel business intends to add between 90 and 180 employees over the next five years to its operations.
 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.